{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01432938","recordId":"NCT01432938","peptideSlug":"dulaglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01432938-dulaglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01432938.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct01432938.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2011-09-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2011-09-09","publishedAt":"2026-08-23","recordId":"NCT01432938","recordSha256":"4f31c40650ad4f812a47322a7d675da1d02e28f0c44ab1fb0347c9aa7d2a5a5a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01432938?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2011-09-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"dulaglutide","submittedDate":"2011-09-16","publishedAt":"2026-08-23","recordId":"NCT01432938","recordSha256":"88faf0d61a5cf2a401810b3f286f4d356d866a418caee6c0cf0949d11f1e7971","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01432938?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2012-01-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"dulaglutide","submittedDate":"2012-01-17","publishedAt":"2026-08-23","recordId":"NCT01432938","recordSha256":"ecd9a78d94eaf3b93d52ce82ad4c96caba085dbc1f0129e91393d4af3882b0eb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01432938?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2012-04-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"dulaglutide","submittedDate":"2012-04-02","publishedAt":"2026-08-23","recordId":"NCT01432938","recordSha256":"63bbad7ad823156359bffb05078ffd80852149e3de481a6f1d390024dd430efb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01432938?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Design","Study Identification","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2014-10-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"dulaglutide","submittedDate":"2014-10-03","publishedAt":"2026-08-23","recordId":"NCT01432938","recordSha256":"dfb7594c2986760f183a58b79fc3c4a686041b5b23ebde098b5f9bdba8a531a1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01432938?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"2c9c7ea4f2a39e4a6df5d045ed706cadb78894cd22e67dd4d7bf1801afc4938a"}}